“…NO is a critical antimicrobial used by the human immune system (Hibbs, et al, 1988), and exogenous administration of NO to infection sites using a number of different delivery mechanisms has produced promising results (Friedman, et al, 2011; Jones, et al, 2010; Robinson, et al, 2014; Sulemankhil, et al, 2012; Sun, et al, 2012) This molecule with diverse functions easily diffuses through the bacterial membranes and reacts with iron-sulfur clusters, superoxide, and oxygen, whereas its oxidized forms damage thiols, DNA, and residues on proteins (Robinson, et al, 2014). This reactivity provides NO with an ability to inhibit or disrupt a diverse set of enzymes and regulatory proteins, which include catalases, respiratory cytochromes, and bacterial reductases (Brown, 1995; Brunelli, et al, 1995; Henard, et al, 2014; Mason, et al, 2009). Such pleotropic effects lead to a complex relationship between NO and antibiotic tolerance.…”